Skip to main content
Top
Published in: Archives of Virology 10/2012

01-10-2012 | Original Article

Pathogenic and vaccine strains of Japanese encephalitis virus elicit different levels of human macrophage effector functions

Authors: Harini Sooryanarain, Gajanan N. Sapkal, Milind M. Gore

Published in: Archives of Virology | Issue 10/2012

Login to get access

Abstract

In India, Japanese encephalitis virus (JEV) remains one of the major causative agents of pediatric encephalitis. Macrophages support various neurotropic viruses and influence the immune response. However, the functional status of human macrophages during JEV infection remains unidentified. In this study, we examined the cytokine response and co-stimulatory marker levels in primary human monocyte derived macrophages (MDMs) infected with JE057434 (neurovirulent, primary clinical isolate) or SA14-14-2 (non-neurovirulent, live-attenuated vaccine) JEV strains. We also examined the differential susceptibility of these JEV strains to antiviral effects of interferon and nitric oxide. The results indicate that both JEV strains are capable of inducing various cytokines (type-I IFN, TNFα, IL6 and IL8) and co-stimulatory molecules (CD86 and CD80) in MDMs. However, they varied in replication potential and corresponding interferon sensitivity. SA14-14-2 was highly susceptible to interferon and nitric oxide when compared to JE057434. Thus, reduction in infectious virion production and increased sensitivity of SA14-14-2 towards interferon in MDMs could potentially play a role in limiting viral spread to additional target tissues.
Appendix
Available only for authorised users
Literature
1.
go back to reference Erlanger ET, Weiss S, Keiser J, Utzinger J, Wiedenmayer K (2009) Past, present, and future of Japanese Encephalitis. Emerg Infect Dis 15(1):1–7PubMedCrossRef Erlanger ET, Weiss S, Keiser J, Utzinger J, Wiedenmayer K (2009) Past, present, and future of Japanese Encephalitis. Emerg Infect Dis 15(1):1–7PubMedCrossRef
2.
go back to reference Gore MM (2004) Japanese encephalitis virus: host-Virus interactions. In: Mishra AC (ed) NIV commemorative compendium, 1st edn. NIV, Pune, pp 357–405 Gore MM (2004) Japanese encephalitis virus: host-Virus interactions. In: Mishra AC (ed) NIV commemorative compendium, 1st edn. NIV, Pune, pp 357–405
4.
go back to reference Kumar P, Krishna DV, Sulochana P, Nirmala G, Haridattatreya M, Satchidanandam V (2004) Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain. J Gen Virol 85:471–482PubMedCrossRef Kumar P, Krishna DV, Sulochana P, Nirmala G, Haridattatreya M, Satchidanandam V (2004) Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain. J Gen Virol 85:471–482PubMedCrossRef
6.
go back to reference Libraty HD, Nisalak A, Endy PT, Suntayakorn S, Vaughn WD, Innis LB (2002) Clinical and immunological risk factors for severe disease in Japanese encephalitis. Trans R Soc Trop Med Hyg 96:173–178PubMedCrossRef Libraty HD, Nisalak A, Endy PT, Suntayakorn S, Vaughn WD, Innis LB (2002) Clinical and immunological risk factors for severe disease in Japanese encephalitis. Trans R Soc Trop Med Hyg 96:173–178PubMedCrossRef
7.
go back to reference Yu YX, Zhang GM, Guo YP, Ao J, Li HM (1988) Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. Am J Trop Med Hyg 39:214–217 Yu YX, Zhang GM, Guo YP, Ao J, Li HM (1988) Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. Am J Trop Med Hyg 39:214–217
8.
go back to reference Kumar R, Tripathi P, Rizvi A (2009) Effectiveness of one dose of SA 14–14-2 vaccine against Japanese Encephalitis. N Engl J Med 360:1465–1466PubMedCrossRef Kumar R, Tripathi P, Rizvi A (2009) Effectiveness of one dose of SA 14–14-2 vaccine against Japanese Encephalitis. N Engl J Med 360:1465–1466PubMedCrossRef
9.
go back to reference Eckels KH, Yu YX, Dubois DR, Marchette NJ, Trent DW, Johnson AJ (1988) Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA 14–14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use. Vaccine 6:513–518PubMedCrossRef Eckels KH, Yu YX, Dubois DR, Marchette NJ, Trent DW, Johnson AJ (1988) Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA 14–14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use. Vaccine 6:513–518PubMedCrossRef
10.
go back to reference Li Y, Yea J, Yanga X, Xua M, Chena L, Meia L, Zhua J, Liua X, Chena H, Cao S (2009) Infection of mouse bone marrow-derived dendritic cells by live attenuated Japanese encephalitis virus induces cells maturation and triggers T cells activation. Vaccine 29:855–862CrossRef Li Y, Yea J, Yanga X, Xua M, Chena L, Meia L, Zhua J, Liua X, Chena H, Cao S (2009) Infection of mouse bone marrow-derived dendritic cells by live attenuated Japanese encephalitis virus induces cells maturation and triggers T cells activation. Vaccine 29:855–862CrossRef
11.
go back to reference Woodson ES, Freiberg NA, Holbrook RM (2011) Differential cytokine responses from primary human Kupffer cells following infection with wild-type or vaccine strain yellow fever virus. Virology 412:188–195PubMedCrossRef Woodson ES, Freiberg NA, Holbrook RM (2011) Differential cytokine responses from primary human Kupffer cells following infection with wild-type or vaccine strain yellow fever virus. Virology 412:188–195PubMedCrossRef
12.
go back to reference Aleyas GA, George AJ, Han WY, Rahman MM, Kim JS, Han BS, Kim SB, Kim K, Eo KS (2009) Functional modulation of dendritic cells and macrophages by Japanese encephalitis virus through MyD88 adaptor molecule-dependent and -independent pathways. J Immunol 183:2462–2474PubMedCrossRef Aleyas GA, George AJ, Han WY, Rahman MM, Kim JS, Han BS, Kim SB, Kim K, Eo KS (2009) Functional modulation of dendritic cells and macrophages by Japanese encephalitis virus through MyD88 adaptor molecule-dependent and -independent pathways. J Immunol 183:2462–2474PubMedCrossRef
13.
go back to reference Mathur A, Bharadwaj M, Kulshreshtha R, Rawat S, Jain A, Chaturvedi UC (1988) Immunopathological study of spleen during Japanese encephalitis virus infection in mice. Br J Exp Pathol 69:423–432PubMed Mathur A, Bharadwaj M, Kulshreshtha R, Rawat S, Jain A, Chaturvedi UC (1988) Immunopathological study of spleen during Japanese encephalitis virus infection in mice. Br J Exp Pathol 69:423–432PubMed
14.
go back to reference Kedarnath N, Gore MM, Dayaraj C, Sathe SP, Ghosh NS (1986) Effect of various mitogens on the replication of Japanese encephalitis virus in human mononuclear leukocyte cultures. Indian J Med Res 84:231–238PubMed Kedarnath N, Gore MM, Dayaraj C, Sathe SP, Ghosh NS (1986) Effect of various mitogens on the replication of Japanese encephalitis virus in human mononuclear leukocyte cultures. Indian J Med Res 84:231–238PubMed
16.
go back to reference King NJ, Getts RD, Getts TM, Rana S, Shrestha B, Kesson MA (2007) Immunopathology of flavivirus infections. Immunol Cell Biol 85:33–42PubMedCrossRef King NJ, Getts RD, Getts TM, Rana S, Shrestha B, Kesson MA (2007) Immunopathology of flavivirus infections. Immunol Cell Biol 85:33–42PubMedCrossRef
17.
go back to reference Dejnirattisai W, Duangchinda T, Lin LC, Vasanawathana S, Jones M, Jacobs M, Malasit P, Xu NX, Screaton G, Mongkolsapaya J (2008) A complex interplay among virus, dendritic cells T cells, and cytokines in dengue virus infections. J Immunol 181:5865–5874PubMed Dejnirattisai W, Duangchinda T, Lin LC, Vasanawathana S, Jones M, Jacobs M, Malasit P, Xu NX, Screaton G, Mongkolsapaya J (2008) A complex interplay among virus, dendritic cells T cells, and cytokines in dengue virus infections. J Immunol 181:5865–5874PubMed
18.
go back to reference Spaeth BG, Longman SR, Albert LM, Rice MC (2005) Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes. J Exp Med 202:1179–1184CrossRef Spaeth BG, Longman SR, Albert LM, Rice MC (2005) Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes. J Exp Med 202:1179–1184CrossRef
19.
go back to reference Winter PM, Dung MN, Loan TH, Kneen R, Wills B, Thu TL, House D, White JN, Farrar JJ, Hart AC, Solomon T (2004) Proinflammatory cytokines and chemokines in humans with Japanese Encephalitis. J Infec Dis 190:1618–1626CrossRef Winter PM, Dung MN, Loan TH, Kneen R, Wills B, Thu TL, House D, White JN, Farrar JJ, Hart AC, Solomon T (2004) Proinflammatory cytokines and chemokines in humans with Japanese Encephalitis. J Infec Dis 190:1618–1626CrossRef
20.
go back to reference Nasveld EP, Ebringer A, Elmes N, Bennett S, Yoksan S, Aaskov J, McCarthy K, Kanesathasan N, Meric C, Reid M (2010) Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine—randomized, double-blind, 5-year phase II study in healthy adults. Human Vaccines 6:1–9CrossRef Nasveld EP, Ebringer A, Elmes N, Bennett S, Yoksan S, Aaskov J, McCarthy K, Kanesathasan N, Meric C, Reid M (2010) Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine—randomized, double-blind, 5-year phase II study in healthy adults. Human Vaccines 6:1–9CrossRef
21.
go back to reference Arroyo J, Guirakhoo F, Fenner S, Zhang ZX, Monath TP, Chambers TJ (2001) Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol 75:934–942PubMedCrossRef Arroyo J, Guirakhoo F, Fenner S, Zhang ZX, Monath TP, Chambers TJ (2001) Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol 75:934–942PubMedCrossRef
22.
go back to reference Pichyangkul S, Endy PT, Kalayanarooj S, Nisalak A, Yongvanitchit K, Green S, Rothman LA, Ennis AF, Libraty HD (2003) A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity. J Immunol 171:5571–5578PubMed Pichyangkul S, Endy PT, Kalayanarooj S, Nisalak A, Yongvanitchit K, Green S, Rothman LA, Ennis AF, Libraty HD (2003) A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity. J Immunol 171:5571–5578PubMed
23.
go back to reference Aguilar PV, Paessler S, Carrara SA, Baron S, Poast J, Wang E, Moncayo CA, Anishchenko M, Watts D, Tesh BR, Weaver CS (2005) Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus. J Virol 79:11300–11310PubMedCrossRef Aguilar PV, Paessler S, Carrara SA, Baron S, Poast J, Wang E, Moncayo CA, Anishchenko M, Watts D, Tesh BR, Weaver CS (2005) Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus. J Virol 79:11300–11310PubMedCrossRef
24.
go back to reference Liang JJ, Liao LC, Liao TJ, Lee LY, Lin LY (2009) A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability. Vaccine 27:2746–2754PubMedCrossRef Liang JJ, Liao LC, Liao TJ, Lee LY, Lin LY (2009) A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability. Vaccine 27:2746–2754PubMedCrossRef
26.
go back to reference Johnson RT, Burke DS, Elwell M, Leake CJ, Nisalak A, Hoke CH, Lorsomrudee W (1985) Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol 18:567–573PubMedCrossRef Johnson RT, Burke DS, Elwell M, Leake CJ, Nisalak A, Hoke CH, Lorsomrudee W (1985) Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol 18:567–573PubMedCrossRef
27.
go back to reference Ravi V, Parida S, Desai A, Chandramuki A, Gourie-Devi M, Grau EG (1997) Correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in Japanese encephalitis patients. J Med Virol 51:132–136PubMedCrossRef Ravi V, Parida S, Desai A, Chandramuki A, Gourie-Devi M, Grau EG (1997) Correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in Japanese encephalitis patients. J Med Virol 51:132–136PubMedCrossRef
29.
go back to reference Hase T, Dubois RD, Summers LP, Downs BM, Ussery AM (1993) Comparison of replication rates and pathogenicities between the SA 14 parent and SA 14–14-2 vaccine strains of Japanese encephalitis virus in mouse brain neurons. Arch Virol 130:131–143PubMedCrossRef Hase T, Dubois RD, Summers LP, Downs BM, Ussery AM (1993) Comparison of replication rates and pathogenicities between the SA 14 parent and SA 14–14-2 vaccine strains of Japanese encephalitis virus in mouse brain neurons. Arch Virol 130:131–143PubMedCrossRef
30.
go back to reference Ni H, Chang JG, Xie H, Trent WD, Barrett A (1995) Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14. J Gen Virol 76:409–413PubMedCrossRef Ni H, Chang JG, Xie H, Trent WD, Barrett A (1995) Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14. J Gen Virol 76:409–413PubMedCrossRef
31.
go back to reference Nitayaphan S, Grant AJ, Chang JG, Trent WD (1990) Nucleotide sequence of the virulent SA- 14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA14-14-2. Virology 177:541–552PubMedCrossRef Nitayaphan S, Grant AJ, Chang JG, Trent WD (1990) Nucleotide sequence of the virulent SA- 14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA14-14-2. Virology 177:541–552PubMedCrossRef
32.
go back to reference Lee E, Lobigs M (2002) Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J Virol 76:4901–4911PubMedCrossRef Lee E, Lobigs M (2002) Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J Virol 76:4901–4911PubMedCrossRef
33.
go back to reference Wang T, Town T, Alexopoulou L, Anderson FJ, Fikrig E, Flavell AR (2004) Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10:1366–1373PubMedCrossRef Wang T, Town T, Alexopoulou L, Anderson FJ, Fikrig E, Flavell AR (2004) Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10:1366–1373PubMedCrossRef
34.
go back to reference Wang PJ, Liu P, Latz E, Golenbock TD, Finberg WR, Libraty HD (2006) Flavivirus activation of plasmocytoid dentritic cells delinates key elements of TLR7 signaling beyond endosomal recognition. J Immunol 177:7114–7121PubMed Wang PJ, Liu P, Latz E, Golenbock TD, Finberg WR, Libraty HD (2006) Flavivirus activation of plasmocytoid dentritic cells delinates key elements of TLR7 signaling beyond endosomal recognition. J Immunol 177:7114–7121PubMed
35.
go back to reference Cao S, Li Y, Ye J, Yang X, Chen L, Liu X, Chen H (2011) Japanese Encephalitis Virus wild strain infection suppresses dendritic cells maturation and function, and causes the expansion of regulatory T cells. Virol J 8:39PubMedCrossRef Cao S, Li Y, Ye J, Yang X, Chen L, Liu X, Chen H (2011) Japanese Encephalitis Virus wild strain infection suppresses dendritic cells maturation and function, and causes the expansion of regulatory T cells. Virol J 8:39PubMedCrossRef
36.
go back to reference Hsu CT, Gao QJ, Lu HK, Tsai HC, Huang YC, Tzang SB (2008) Japanese encephalitis virus envelope protein mitigates TNF-alpha mRNA expression in RAW264.7 cells. Inflammation 31:133–140PubMedCrossRef Hsu CT, Gao QJ, Lu HK, Tsai HC, Huang YC, Tzang SB (2008) Japanese encephalitis virus envelope protein mitigates TNF-alpha mRNA expression in RAW264.7 cells. Inflammation 31:133–140PubMedCrossRef
37.
go back to reference Arjona A, Ledizet M, Anthony K, Bonafé N, Modis Y, Town T, Fikrig E (2007) West Nile virus envelope protein inhibits dsRNA-induced innate immune responses. J Immunol 179:8403–8409PubMed Arjona A, Ledizet M, Anthony K, Bonafé N, Modis Y, Town T, Fikrig E (2007) West Nile virus envelope protein inhibits dsRNA-induced innate immune responses. J Immunol 179:8403–8409PubMed
38.
go back to reference Samuel AM, Diamond SM (2005) Alpha/beta interferon protects against lethal west nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 79:13350–13361PubMedCrossRef Samuel AM, Diamond SM (2005) Alpha/beta interferon protects against lethal west nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 79:13350–13361PubMedCrossRef
39.
go back to reference Diamond M, Roberts T, Edgil D, Lu B, Ernst J, Harris E (2000) Modulation of dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol 74:4957–4966PubMedCrossRef Diamond M, Roberts T, Edgil D, Lu B, Ernst J, Harris E (2000) Modulation of dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol 74:4957–4966PubMedCrossRef
40.
go back to reference Macejak D, Jensen K, Pavco P, Phipps K, Heinz B, Colacino J, Blatt L (2001) Enhanced antiviral effect in cell culture of type 1 interferon and ribozymes targeting HCV RNA. J Viral Hepat 8:400–405PubMedCrossRef Macejak D, Jensen K, Pavco P, Phipps K, Heinz B, Colacino J, Blatt L (2001) Enhanced antiviral effect in cell culture of type 1 interferon and ribozymes targeting HCV RNA. J Viral Hepat 8:400–405PubMedCrossRef
41.
go back to reference Lin R, Liao C, Lin E, Lin LY (2004) Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. J Virol 78:9285–9294PubMedCrossRef Lin R, Liao C, Lin E, Lin LY (2004) Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. J Virol 78:9285–9294PubMedCrossRef
42.
go back to reference Vrati S, Agarwal V, Malik P, Wani SA, Saini M (1999) Molecular characterization of an Indian isolate of Japanese encephalitis virus that shows an extended lag phase during growth. J Gen Virol 80:1665–1671PubMed Vrati S, Agarwal V, Malik P, Wani SA, Saini M (1999) Molecular characterization of an Indian isolate of Japanese encephalitis virus that shows an extended lag phase during growth. J Gen Virol 80:1665–1671PubMed
43.
go back to reference Seitz C, Frensing T, Höper D, Kochs G, Reichl U (2010) High yields of influenza A virus in Madin–Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state. J Gen Virol 91:1754–1763PubMedCrossRef Seitz C, Frensing T, Höper D, Kochs G, Reichl U (2010) High yields of influenza A virus in Madin–Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state. J Gen Virol 91:1754–1763PubMedCrossRef
44.
go back to reference Ashour J, Laurent-Rolle M, Shi PY, García-Sastre A (2009) NS5 of dengue virus mediates STAT2 binding and degradation. J Virol 83:5408–5418PubMedCrossRef Ashour J, Laurent-Rolle M, Shi PY, García-Sastre A (2009) NS5 of dengue virus mediates STAT2 binding and degradation. J Virol 83:5408–5418PubMedCrossRef
45.
go back to reference Lin Y, Huang LY, Ma S, Yeh C, Chiou S, Chen L, Liao C (1997) Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J Virol 71:5227–5235PubMed Lin Y, Huang LY, Ma S, Yeh C, Chiou S, Chen L, Liao C (1997) Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J Virol 71:5227–5235PubMed
46.
go back to reference Pacher P, Beckman J, Liaudet L (2007) Nitric Oxide and Peroxynitrite in Health and Disease. Physiol Rev 87:315–424PubMedCrossRef Pacher P, Beckman J, Liaudet L (2007) Nitric Oxide and Peroxynitrite in Health and Disease. Physiol Rev 87:315–424PubMedCrossRef
Metadata
Title
Pathogenic and vaccine strains of Japanese encephalitis virus elicit different levels of human macrophage effector functions
Authors
Harini Sooryanarain
Gajanan N. Sapkal
Milind M. Gore
Publication date
01-10-2012
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 10/2012
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-012-1386-8

Other articles of this Issue 10/2012

Archives of Virology 10/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.